Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 Dec;31(8):922-943.
doi: 10.1037/adb0000326.

A scoping review and meta-analysis of psychosocial and pharmacological treatments for cannabis and tobacco use among African Americans

Affiliations
Meta-Analysis

A scoping review and meta-analysis of psychosocial and pharmacological treatments for cannabis and tobacco use among African Americans

LaTrice Montgomery et al. Psychol Addict Behav. 2017 Dec.

Abstract

The rates of co-occurring cannabis and tobacco use are higher among African Americans relative to other racial/ethnic groups. One plausible approach to treating co-use among African Americans is to examine the effectiveness of treatments for the sole use of cannabis and tobacco to identify effective approaches that might be combined to treat the dual use of these substances. The current meta-analysis sought to include studies that reported cannabis and/or tobacco use outcomes from randomized clinical trials (RCTs) with 100% African American samples. A total of 843 articles were considered for inclusion, 29 were reviewed by independent qualitative coders, and 22 were included in the review. There were no articles on cannabis use treatment with a 100% African American sample, resulting in a need to lower the threshold (60%) and conduct a scoping review of cannabis studies. Preliminary evidence from a small number of studies (k = 7) supports the use of Motivational Interviewing and Cognitive-Behavioral Therapy to treat cannabis use among African Americans, but not Contingency Management. Results from a meta-analysis of 15 tobacco studies found higher rates of smoking abstinence in the treatment condition relative to control conditions overall and across short and long-term follow-up periods. Significant differences in smoking abstinence were also found when examining the effects of pharmacological treatments relative to their control conditions. The clinical and research implications of these findings for future psychosocial and pharmacological trials for cannabis and tobacco use and co-use among African Americans are described. (PsycINFO Database Record

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flow diagram for search strategy.
Figure 2.
Figure 2.
Effect sizes and confidence intervals for tobacco treatment and control interventions for African Americans.
Figure 3.
Figure 3.
Funnel plot of precision to detect publication bias.

Similar articles

Cited by

References

    1. Agrawal A, Budney AJ, & Lynskey MT (2012). The co-occurring use and misuse of cannabis and tobacco: A review. Addiction, 107, 1221–1233. 10.1111/j.1360-0443.2012.03837.x - DOI - PMC - PubMed
    1. Ahluwalia JS, Harris KJ, Catley D, Okuyemi KS, & Mayo MS (2002). Sustained-release bupropion for smoking cessation in African Americans: A randomized controlled trial. Journal of the American Medical Association, 288, 468–474. 10.1001/jama.288.4.468

      *

    1. Ahluwalia JS, McNagny SE, & Clark WS (1998). Smoking cessation among inner-city African Americans using the nicotine transdermal patch. Journal of General Internal Medicine, 13, 1–8. 10.1046/j.1525-1497.1998.00001.x

      *

    1. Ahluwalia JS, Okuyemi K, Nollen N, Choi WS, Kaur H, Pulvers K, & Mayo MS (2006). The effects of nicotine gum and counseling among African American light smokers: A 2 ˣ 2 factorial design. Addiction, 101, 883–891. 10.1111/j.1360-0443.2006.01461.x

      *

    1. Ahluwalia JS, Richter KP, Mayo MS, & Resnicow K (1999). Quit for Life: A randomized trial of culturally sensitive materials for smoking cessation in African Americans. Journal of General Internal Medicine, 14(Suppl. 2), 6.

      *

MeSH terms